Sutro Biopharma Inc Deep Dive Research Forum: Next-Gen Innovations in ADCs Transcript
Good afternoon, and welcome to the Sutro Biopharma Virtual Deep Dive Research Forum, Next-Gen Innovations in ADCs. (Operator Instructions) Please be advised that the call is being recorded at the company's request and will be available on the company's website for at least 30 days.
I would now like to turn the call over to Bill Newell, Chief Executive Officer at Sutro Biopharma. Sir, please go ahead.
Thank you all, operator. Good afternoon, everyone, and thank you for joining us.
With me on the call today are Dr. Trevor Hallam, our President of Research and Chief Scientific Officer; Dr. Kristin Bedard, our Vice President, Discovery; Dr. Shabbir Anik, our Chief Technical Operations Officer; and Dr. Venkatesh Srinivasan, our Senior Vice President, Process and Analytical Development.
Before we start, I would like to remind you that today's call will include forward-looking statements. These forward-looking statements are based on Sutro's expectations and assumptions as of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |